Verition Fund Management LLC Halozyme Therapeutics, Inc. Transaction History

Verition Fund Management LLC

$16.5 Billion
Q2 2024

A detailed history of Verition Fund Management LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Verition Fund Management LLC holds 4,636 shares of HALO stock, worth $234,442. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,636

Previous 6,243 25.74%

Holding current value

$234,442

Previous $253,000 4.35%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$37.81 - $52.4 $60,760 - $84,206	-1,607 Reduced 25.74%	4,636 $242,000
Q1 2024 May 14, 2024	SELL	$33.68 - $41.95 $120,843 - $150,516	-3,588 Reduced 36.5%	6,243 $253,000
Q4 2023 Feb 14, 2024	SELL	$33.32 - $42.1 $16,526 - $20,881	-496 Reduced 4.8%	9,831 $363,000
Q3 2023 Nov 14, 2023	BUY	$36.46 - $44.03 $34,272 - $41,388	940 Added 10.01%	10,327 $394,000
Q2 2023 Aug 14, 2023	SELL	$30.28 - $38.74 $65,283 - $83,523	-2,156 Reduced 18.68%	9,387 $338,000
Q1 2023 May 15, 2023	BUY	$32.86 - $55.7 $379,302 - $642,945	11,543 New	11,543 $440,000
Q2 2022 Aug 15, 2022	BUY	$37.35 - $48.3 $555,655 - $718,559	14,877 New	14,877 $655,000
Q1 2022 May 13, 2022	SELL	$31.97 - $41.06 $3.41 Million - $4.38 Million	-106,663 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$31.82 - $40.75 $3.39 Million - $4.35 Million	106,663 New	106,663 $4.29 Million
Q3 2021 Nov 15, 2021	SELL	$38.47 - $46.42 $1.39 Million - $1.68 Million	-36,260 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$38.84 - $51.31 $1.06 Million - $1.4 Million	27,374 Added 308.06%	36,260 $1.65 Million
Q1 2021 May 18, 2021	BUY	$39.51 - $51.45 $351,085 - $457,184	8,886 New	8,886 $370,000
Q4 2020 Feb 16, 2021	SELL	$25.81 - $43.62 $385,394 - $651,333	-14,932 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$25.74 - $29.63 $384,349 - $442,435	14,932 New	14,932 $392,000
Q2 2020 Aug 14, 2020	SELL	$16.25 - $26.81 $274,462 - $452,820	-16,890 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$13.9 - $21.83 $803,364 - $1.26 Million	-57,796 Reduced 77.39%	16,890 $304,000
Q4 2019 Feb 14, 2020	BUY	$14.93 - $19.53 $177,293 - $231,918	11,875 Added 18.91%	74,686 $1.32 Million
Q3 2019 Nov 14, 2019	BUY	$15.2 - $17.69 $368,463 - $428,823	24,241 Added 62.85%	62,811 $974,000
Q2 2019 Aug 14, 2019	BUY	$14.75 - $17.26 $568,907 - $665,718	38,570 New	38,570 $663,000
Q4 2018 Feb 14, 2019	SELL	$13.33 - $18.66 $133,886 - $187,421	-10,044 Closed	0 $0
Q3 2018 Nov 15, 2018	BUY	$16.68 - $18.41 $167,533 - $184,910	10,044 New	10,044 $182,000

Others Institutions Holding HALO

# of Institutions

511

Shares Held

125M

Call Options Held

208K

Put Options Held

77.1K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $7.04B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.

Account

Verition Fund Management LLC Halozyme Therapeutics, Inc. Transaction History